No Fast Track For Lecanemab In EU Disappoints Eisai

Pan-EU Approval Could Come In March 2024, Says Company

EMA
Lecanemab could be approved in the European Union by March 2024 - well over a year after the US accelerated approval. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Clinical Trials

More from R&D